Saskia Eckert

发表

Development of antidotes: problems and strategies.

K. Kehe, P. Eyer, F. Worek, 2007, Toxicology.

Particulate matter in air at indoor go-kart facilities in Bavaria, Germany

H. Fromme, L. Fembacher, C. Scheu, 2018, Atmospheric Environment.

Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.

P. Eyer, F. Worek, H. Mückter, 2006, Biochemical pharmacology.

Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.

P. Eyer, F. Worek, H. Thiermann, 2008, Toxicology.

Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods.

P. Eyer, F. Worek, H. Thiermann, 2008, Biochemical pharmacology.

Development of a dynamic model for real-time determination of membrane-bound acetylcholinesterase activity upon perfusion with inhibitors and reactivators.

P. Eyer, F. Worek, H. Mückter, 2006, Biochemical pharmacology.

Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.

P. Eyer, F. Worek, H. Thiermann, 2008, Biochemical Pharmacology.

Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.

P. Eyer, F. Worek, Saskia Eckert, 2007, Toxicology.